FDA — authorised 12 December 1980
- Application: NDA018555
- Marketing authorisation holder: ASTRAZENECA
- Local brand name: YUTOPAR
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Ritodrine Oral Tablet in United States
FDA authorised Ritodrine Oral Tablet on 12 December 1980
Marketing authorisations
FDA
- Status: approved
FDA
- Application: NDA018580
- Marketing authorisation holder: ASTRAZENECA
- Local brand name: YUTOPAR
- Indication: INJECTABLE — INJECTION
- Status: approved
Ritodrine Oral Tablet in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Ritodrine Oral Tablet approved in United States?
Yes. FDA authorised it on 12 December 1980; FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Ritodrine Oral Tablet in United States?
ASTRAZENECA holds the US marketing authorisation.